Status:
COMPLETED
Pregnancy and Dilated Cardiomyopathy
Lead Sponsor:
Nantes University Hospital
Conditions:
Dilated Cardiomyopathy
Eligibility:
FEMALE
18+ years
Brief Summary
Increasing cases of women with dilated cardiomyopathy with a project of pregnancy are observed. However there is few knowledge and publications about cardiac diseases in pregnant women. Moreover the m...
Detailed Description
This study is a national (20 centres) retrospective (10 years) and prospective registry of pregnant women with dilated cardiomyopathy. As this study is observational, medical attention of the enrolle...
Eligibility Criteria
Inclusion
- Patients over the age of majority
- Followed-up for non-ischemic left heart failure, diagnosed before or during the pregnancy or with peripartum history, with a left ventricular ejection fraction \< 50% and/or a left ventricle diameter \> 27 mm/m2
- In New York Heart Association (NYHA) class 1 to 4
- Pregnant or with pregnancy history
- Patients with left ventricular non-compaction, valvular cardiomyopathy operated or not can also be enrolled
Exclusion
- Refusal for participation
- Ischemic, hypertrophic, restrictive and congenital cardiomyopathies
Key Trial Info
Start Date :
January 2 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT03235063
Start Date
January 2 2013
End Date
June 30 2021
Last Update
September 9 2021
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Angers
Angers, France, 49100
2
Chru de Brest
Brest, France, 29609
3
Hospital Henri Mondor
Créteil, France, 94010
4
Chru Lille
Lille, France, 59000